Figure 1
Figure 1. TBI causes sustained quantitative reduction of MPPs but not of HPCs and HSCs. C57BL/6 mice were exposed to a sublethal dose (6 Gy) of TBI or were sham irradiated as a control (CTL). Two months after TBI, BM cells (BMCs) were harvested from the 2 hind legs of individual mice for analysis. (A) Representative gating strategy of flow cytometric analysis for HPCs (Lin–Sca1–c-kit+ cells), LSK cells (Lin–Sca1+c-kit+ cells), MPPs (CD150–CD48–LSK cells), HSCs (CD150+CD48–LSK cells), ST-HSCs (CD34+CD150+CD48–LSK cells), and LT-HSCs (CD34–CD150+CD48–LSK cells) in lineage-negative (Lin–) BM-MNCs is shown. (B) Frequencies (upper panel) and total numbers (lower panel) of HPCs, LSK cells, MPPs, HSCs, ST-HSCs, and LT-HSCs in BMCs from each mouse are presented as mean ± SD (n = 6-8 mice/group). *P < .05, **P < .01, and ***P < .001, TBI vs CTL.

TBI causes sustained quantitative reduction of MPPs but not of HPCs and HSCs. C57BL/6 mice were exposed to a sublethal dose (6 Gy) of TBI or were sham irradiated as a control (CTL). Two months after TBI, BM cells (BMCs) were harvested from the 2 hind legs of individual mice for analysis. (A) Representative gating strategy of flow cytometric analysis for HPCs (LinSca1c-kit+ cells), LSK cells (LinSca1+c-kit+ cells), MPPs (CD150CD48LSK cells), HSCs (CD150+CD48LSK cells), ST-HSCs (CD34+CD150+CD48LSK cells), and LT-HSCs (CD34CD150+CD48LSK cells) in lineage-negative (Lin) BM-MNCs is shown. (B) Frequencies (upper panel) and total numbers (lower panel) of HPCs, LSK cells, MPPs, HSCs, ST-HSCs, and LT-HSCs in BMCs from each mouse are presented as mean ± SD (n = 6-8 mice/group). *P < .05, **P < .01, and ***P < .001, TBI vs CTL.

Close Modal

or Create an Account

Close Modal
Close Modal